Functional impairment in patients with major depression in clinical remission: Results from the VIVAL-D-Rem, a nationwide, naturalistic, cross-sectional survey

International Clinical Psychopharmacology

Volumn 30, Issue 3, 2015, Pages 129-141

  Sacchetti, Emilio ^a,b   Frank, Ellen ^e   Siracusano, Alberto ^c   Racagni, Giorgio ^d   Vita, Antonio ^a,b   Turrina, Cesare ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SPEDALI CIVILI   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant treatment; Functioning; Major depression; Outpatients; Remission

Indexed keywords

BENZODIAZEPINE DERIVATIVE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

ARTICLE; CHILD; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FUNCTIONAL DISEASE; HAMILTON DEPRESSION RATING SCALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CENTER; PREDICTIVE VALUE; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SHORT FORM 12; ADULT; CONVALESCENCE; DEPRESSIVE DISORDER, MAJOR; ITALY; MIDDLE AGED; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STANDARDS;

ADULT; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECOVERY OF FUNCTION; REMISSION INDUCTION;

EID: 84927168951     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0000000000000074     Document Type: Article

References (104)

1. Agosti V (1999). Predictors of persistent social impairment among recovered depressed outpatients. J Affect Disord 55 :215-219.
2. Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, et al. (2008). Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22:343-396.
3. th ed. Washington, DC: APA.
4. rd ed. Washington, DC: APA.
5. Apollone G, Mosconi P, Quattrociocchi L, Gianicolo EAL, Groth N, Ware JE Jr (2005). Questionario sullo stato di salute SF-12. Versione italiana [Health Questionnaire SF-12. Italian version]. Milan: Institute of Pharmacological Research Mario Negri.
6. Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Möller HJ, World Federation of Societies of Biological Psychiatry. Task Force on Unipolar Depressive Disorders (2013). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry 14:334-385.
7. Bauwens F, Tracy A, Pardoen D, Vander Elst M, Mendlewicz J (1991). Social adjustment of remitted bipolar and unipolar out-patients. A comparison with age- and sex-matched controls. Br J Psychiatry 159:239-244.
8. Billings AG, Moos RH (1985). Psychosocial processes of remission in unipolar depression: comparing depressed patients with matched community controls. J Consult Clin Psychol 53:314-325.
9. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, Fauerbach JA (2001). Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 88:337-341.
10. Carmody TJ, Rush AJ, Bernstein I, Warden D, Brannan S, Burnham D, et al. (2006). The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. Eur Neuropsychopharmacol 16:601-611.
11. Conradi HJ, Ormel J, de Jonge P (2011). Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med 41:1165-1174.
12. Conradi HJ, Ormel J, de Jonge P (2012). Symptom profiles of DSM-IV-defined remission, recovery, relapse, and recurrence of depression: the role of the core symptoms. Depress Anxiety 29:638-645.
13. Coryell W, Scheftner W, Keller M, Endicott J, Maser J, Klerman GL (1993). The enduring psychosocial consequences of mania and depression. Am J Psychiatry 150:720-727.
14. Cronin-Stubbs D, de Leon CF, Beckett LA, Field TS, Glynn RJ, Evans DA (2000). Six-year effect of depressive symptoms on the course of physical disability in community-living older adults. Arch Intern Med 160:3074-3080.
15. Cuffel BJ, Azocar F, Tomlin M, Greenfield SF, Busch AB, Croghan TW (2003). Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice. J Clin Psychiatry 64:397-402.
16. Dombrovski AY, Mulsant BH, Houck PR, Mazumdar S, Lenze EJ, Andreescu C, et al. (2007). Residual symptoms and recurrence during maintenance treatment of late-life depression. J Affect Disord 103:77-82.
17. Endicott J, Cohen J, Nee J, Fleiss J, Sarantakos S (1981). Hamilton Depression Rating Scale. Extracted from regular and change versions of the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 38:98-103.
18. Faravelli C (2004). Assessment of psychopathology. Psychother Psychosom 73:139-141.
19. Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ (2000). The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res 34:3-10.
20. Fava GA (1999). Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med 29:47-61.
21. Fava GA (2006). The intellectual crisis of psychiatric research. Psychother Psychosom 75:202-208.
22. Fava GA, Kellner R (1991). Prodromal symptoms in affective disorders. Am J Psychiatry 148:823-830.
23. Fava GA, Grandi S, Zielezny M, Canestrari R, Morphy MA (1994). Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 151:1295-1299.
24. Fava M, Evins AE, Dorer DJ, Schoenfeld DA (2003). The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother Psychosom 72:115-127.
25. Fava GA, Ruini C, Belaise C (2007). The concept of recovery in major depression. Psychol Med 37:307-317.
26. Flint AJ, Rifat SL (1997). Two-year outcome of elderly patients with anxious depression. Psychiatry Res 66:23-31.
27. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48:851-855.
28. Furukawa TA, Takeuchi H, Hiroe T, Mashiko H, Kamei K, Kitamura T, Takahashi K (2001). Symptomatic recovery and social functioning in major depression. Acta Psychiatr Scand 103:257-261.
29. Gastó C, Navarro V, Catalán R, Portella MJ, Marcos T (2003). Residual symptoms in elderly major depression remitters. Acta Psychiatr Scand 108:15-19.
30. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-42.
31. Hees HL, Koeter MW, Schene AH (2012). Predictors of long-term return to work and symptom remission in sick-listed patients with major depression. J Clin Psychiatry 73:e1048-e1055.
32. Hirschfeld RM, Dunner DL, Keitner G, Klein DN, Koran LM, Kornstein SG, et al. (2002). Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry 51:123-133.
33. Hybels CF, Steffens DC, McQuoid DR, Rama Krishnan KR (2005). Residual symptoms in older patients treated for major depression. Int J Geriatr Psychiatry 20:1196-1202.
34. Iovieno N, van Nieuwenhuizen A, Clain A, Baer L, Nierenberg AA (2011). Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse. Depress Anxiety 28:137-144.
35. Judd LL, Akiskal HS, Paulus MP (1997). The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord 45:5-17.
36. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. (1998a). A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 55:694-700.
37. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. (1998b). Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50:97-108.
38. Judd LL, Paulus MP, Zeller P (1999). The role of residual subthreshold depressive symptoms in early episode relapse in unipolar major depressive disorder. Arch Gen Psychiatry 56:764-765.
39. Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, et al. (2000a). Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 57:375-380.
40. Judd LL, Paulus MJ, Schettler PJ, Akiskal HS, Endicott J, Leon AC, et al. (2000b). Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 157:1501-1504.
41. Kearns NP, Kruickshank CA, McGuigan KJ, Riley SA, Shaw SP, Snaith RP (1982). A comparison of depression rating scales. Br J Psychiatry 141:45-49.
42. Keller MB (2004). Remission versus response: the new gold standard of antidepressant care. J Clin Psychiatry 65: (Suppl 4):53-59.
43. Kennedy N, Paykel ES (2004). Residual symptoms at remission from depression: impact on long-term outcome. J Affect Disord 80:135-144.
44. Kiosses DN, Alexopoulos GS (2013). The prognostic significance of subsyndromal symptoms emerging after remission of late-life depression. Psychol Med 43:341-350.
45. Laird NM (1992). Estimating rates of change in clinical studies. In: Fava M, Rosenbaum JF, editors. Research designs and methods in psychiatry. Amsterdam: Elsevier Science. pp. 185-193.
46. Lecrubier Y (2002). How do you define remission? Acta Psychiatr Scand Suppl 106 (Suppl 415):7-11.
47. Manhert FA, Reicher H, Zalaudek K, Zapotoczky HG (1997). Prodromal and residual symptoms in recurrent depression: preliminary data of a long-term study under prophylactic treatment condition. Eur Neuropsychopharmacol 7 (Suppl 6):s159-s160.
48. McClintock SM, Husain MM, Wisniewski SR, Nierenberg AA, Stewart JW, Trivedi MH, et al. (2011). Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol 31:180-186.
49. McIntyre R, Kennedy S, Bagby RM, Bakish D (2002). Assessing full remission. J Psychiatry Neurosci 27:235-239.
50. McIntyre RS, O'Donovan C (2004). The human cost of not achieving full remission in depression. Can J Psychiatry 49 (Suppl 1):10S-16S.
51. Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, et al. (1998). The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 59:608-619.
52. Mintz J, Mintz LI, Arruda MJ, Hwang SS (1992). Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 49:761-768.
53. Mojtabai R (2001). Residual symptoms and impairment in major depression in the community. Am J Psychiatry 158:1645-1651.
54. Möller HJ (2008). Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment. World J Biol Psychiatry 9:102-114.
55. Montgomery SA, Doogan DP, Burnside R (1991). The influence of different relapse criteria on the assessment of long-term efficacy of sertraline. Int Clin Psychopharmacol 6 (Suppl 2):37-46.
56. Murray CJ, Lopez AD (1997a). Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349:1498-1504.
57. Murray CJ, Lopez AD (1997b). Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349:1436-1442.
58. Myrtek M, Foerster F (1986). The law of initial value: a rare exception. Biol Psychol 22:227-237.
59. National Collaborating Centre for Mental Health commissioned by the National Institute for Health & Clinical Excellence. Depression. (NICE) (2010). Guideline on the treatment and management of depression in adults (updated edition). London: The British Psychological Society and The Royal College of Psychiatrists.
60. Nierenberg AA, Wright EC (1999). Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry 60: (Suppl 22):7-11.
61. Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ 3rd, et al. (1999). Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 60:221-225.
62. Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR, et al. (2010). Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR∗D report. Psychol Med 40:41-50.
63. Nierenberg AA, Bentley KH, Farabaugh AH, Fava M, Deckersbach T (2012). The absence of depressive symptoms is not the presence of wellness: validation of the Clinical Positive Affect Scale. Aust N Z J Psychiatry 46:1165-1172.
64. Ogrodniczuk JS, Piper WE, Joyce AS (2004). Residual symptoms in depressed patients who successfully respond to short-term psychotherapy. J Affect Disord 82:469-473.
65. Ormel J, Oldehinkel T, Brilman E, vanden Brink W(1993). Outcome of depression and anxiety in primary care. A three-wave 3 1/2-year study of psychopathology and disability. Arch Gen Psychiatry 50:759-766.
66. Ormel J, Oldehinkel AJ, Vollebergh W (2004). Vulnerability before, during, and after a major depressive episode: a 3-wave population-based study. Arch Gen Psychiatry 61:990-996.
67. Papakostas GI, Petersen T, Denninger JW, Tossani E, Pava JA, Alpert JE, et al. (2004). Psychosocial functioning during the treatment of major depressive disorder with fluoxetine. J Clin Psychopharmacol 24:507-511.
68. Patten SB, Kennedy SH, Lam RW, O'Donovan C, Filteau MJ, Parikh SV, Ravindran AV, Canadian Network for Mood and Anxiety Treatments (CANMAT) (2009). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord 117 (Suppl 1):S5-S14.
69. Paykel ES (1998). Remission and residual symptomatology in major depression. Psychopathology 31:5-14.
70. Paykel ES (2008). Partial remission, residual symptoms, and relapse in depression. Dialogues Clin Neurosci 10:431-437.
71. Paykel ES, Weissman MM (1973). Social adjustment and depression. A longitudinal study. Arch Gen Psychiatry 28:659-663.
72. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A (1995). Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25:1171-1180.
73. Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, van Tilburg W (2001). Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 58:221-227.
74. Petty SC, Sachs-Ericsson N, Joiner TE Jr (2004). Interpersonal functioning deficits: temporary or stable characteristics of depressed individuals? J Affect Disord 81:115-122.
75. Philipp M, Fickinger MP (1993). The definition of remission and its impact on the length of a depressive episode. Arch Gen Psychiatry 50:407-408.
76. Pintor L, Gastó C, Navarro V, Torres X, Fañanas L (2003). Relapse of major depression after complete and partial remission during a 2-year follow-up. J Affect Disord 73 :237-244.
77. Pintor L, Torres X, Navarro V, Matrai S, Gastó C (2004). Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up? J Affect Disord 82:291-296.
78. Ramana R, Paykel ES, Cooper Z, Hayhurst H, Saxty M, Surtees PG (1995). Remission and relapse in major depression: a two-year prospective follow-up study. Psychol Med 25:1161-1170.
79. Riso LP, Thase ME, Howland RH, Friedman ES, Simons AD, Tu XM (1997). A prospective test of criteria for response, remission, relapse, recovery, and recurrence in depressed patients treated with cognitive behavior therapy. J Affect Disord 43:131-142.
80. Romera I, Perez V, Menchón JM, Delgado-Cohen H, Polavieja P, Gilaberte I (2010). Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study. Eur Psychiatry 25:58-65.
81. Romera I, Pérez V, Menchón JM, Polavieja P, Gilaberte I (2011). Optimal cutoff point of the Hamilton Rating Scale for Depression according to normal levels of social and occupational functioning. Psychiatry Res 186:133-137.
82. Romera I, Perez V, Ciudad A, Caballero L, Roca M, Polavieja P, Gilaberte I (2013). Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis. BMC Psychiatry 13:51.
83. Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, et al. (2006). Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 31:1841-1853.
84. Rush AJ, First MB, Blacker D (2008). Handbook of psychiatric measures. Washington, DC: American Psychiatric Publishing.
85. Shapira B, Zislin J, Gelfin Y, Osher Y, Gorfine M, Souery D, et al. (1999). Social adjustment and self-esteem in remitted patients with unipolar and bipolar affective disorder: a case-control study. Compr Psychiatry 40:24-30.
86. Shea MT, Leon AC, Mueller TI, Solomon DA, Warshaw MG, Keller MB (1996). Does major depression result in lasting personality change? Am J Psychiatry 153:1404-1410.
87. Simon GE (2000). Long-term prognosis of depression in primary care. Bull World Health Organ 78:439-445.
88. Simon GE, Revicki D, Heiligenstein J, Grothaus L, VonKorff M, KatonWJ, Hylan TR (2000). Recovery from depression, work productivity, and health care costs among primary care patients. Gen Hosp Psychiatry 22:153-162.
89. Simons AD, Murphy GE, Levine JL, Wetzel RD (1986). Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year. Arch Gen Psychiatry 43:43-48.
90. Tedlow J, Fava M, Uebelacker L, Nierenberg AA, Alpert JE, Rosenbaum J (1998). Outcome definitions and predictors in depression. Psychother Psychosom 67:266-270.
91. Thase ME (2003). Evaluating antidepressant therapies: remission as the optimal outcome. J Clin Psychiatry 64 (Suppl 13):18-25.
92. Thase ME, Simons AD, McGeary J, Cahalane JF, Hughes C, Harden T, Friedman E (1992). Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry 149:1046-1052.
93. Thase ME, Entsuah AR, Rudolph RL (2001). Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 178:234-241.
94. Trivedi MH, Morris DW, Wisniewski SR, Lesser I, Nierenberg AA, Daly E, et al. (2013). Increase in work productivity of depressed individuals with improvement in depressive symptom severity. Am J Psychiatry 170:633-641.
95. Van Londen L, Molenaar RP, Goekoop JG, Zwinderman AH, Rooijmans HG (1998). Three- to 5-year prospective follow-up of outcome in major depression. Psychol Med 28:731-735.
96. Ware J Jr, Kosinski M, Keller SD (1996). A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220-233.
97. Zimmerman M, Posternak MA, Chelminski I (2004a). Implications of using different cut-offs on symptom severity scales to define remission from depression. Int Clin Psychopharmacol 19:215-220.
98. Zimmerman M, Posternak MA, Chelminski I (2004b). Defining remission on the Montgomery-Asberg depression rating scale. J Clin Psychiatry 65:163-168.
99. Zimmerman M, Posternak MA, Chelminski I (2005). Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high? J Nerv Ment Dis 193:170-175.
100. Zimmerman M, McGlinchey JB, Posternak MA, Friedman M, Attiullah N, Boerescu D (2006). How should remission from depression be defined? The depressed patient's perspective. Am J Psychiatry 163:148-150.
101. Zimmerman M, Posternak MA, Chelminski I (2007). Heterogeneity among depressed outpatients considered to be in remission. Compr Psychiatry 48:113-117.
102. Zimmerman M, Galione JN, Attiullah N, Friedman M, Toba C, Boerescu DA, et al. (2011). Depressed patients' perspectives of 2 measures of outcome: the Quick Inventory of Depressive Symptomatology (QIDS) and the Remission from Depression Questionnaire (RDQ). Ann Clin Psychiatry 23:208-212.
103. Zimmerman M, Martinez J, Attiullah N, Friedman M, Toba C, Boerescu DA, Rahgeb M (2012a). Further evidence that the cutoff to define remission on the 17-item Hamilton Depression Rating Scale should be lowered. Depress Anxiety 29:159-165.
104. Zimmerman M, Martinez J, Attiullah N, Friedman M, Toba C, Boerescu DA (2012b). Symptom differences between depressed outpatients who are in remission according to the Hamilton Depression Rating Scale who do and do not consider themselves to be in remission. J Affect Disord 142:77-81.